Pregnancy and lactation in relation to breast cancer risk
- PMID: 392771
Pregnancy and lactation in relation to breast cancer risk
Abstract
In the past, numerous efforts have been made to define risk and protective factors of breast cancer. Among these, pregnancy and lactation have been extensively discussed in connection with breast cancer. Unfortunately, many of the reports on the protective effects of pregnancy and lactation are equivocal; caution needs to be exercised when interpreting the results of a single publication. Development of breast cancer is often preceded by the occurrence of preneoplastic mammary lesions, which may be the result of long-term exposure to estrogens and prolactin. Since endogenous estrogen levels regulate pituitary prolactin secretion to some extent, it has been postulated that a hormonal imbalance exists in early mammary carcinogenesis. Exogenous estrogens directly increase pituitary prolactin secretion. During gestation, greatly increased levels of endogenous sex steroids efficiently stimulate pituitary prolactin secretion; during lactation, the stimulus of suckling is responsible for hyperprolactinemia. However, most studies did not reveal a cause-effect relationship between prolactin levels and enhanced risk of breast cancer. At present, the role of pregnancy and lactation in the development and prognosis of breast cancer is not determined.
PIP: After reviewing recent studies concerning the relationship between pregnancy and lactation and the risk of breast cancer, the conclusion was reached that the nature and the direction of the relationship remains undetermined. During pregnancy and lactation, the levels of estrogen and prolactin are increased, and some studies demonstrate that high levels of estrogen and prolactin are associated with the development of breast cancer. Other investigations support the contention that pregnancy and lactation provide protection against breast cancer. Some experts believe that decreased mitotic activity in breast tissue during pregnancy and lactation may afford protection against breast malignancy. Other experts suggest that the high levels of estriol and progesterone, which occur during pregnancy, may protect women from the carcinogenic influence of estradiol and estrone. A number of studies support the contention that the risk of developing breast cancer is reduced for women who experience their 1st pregnancy at a young age and increased for women who experience their 1st pregnancy after the age of 30; however, these findings are not accepted by all investigators.
Similar articles
-
Epidemiologic aspects of exogenous progestagens in relation to their role in pathogenesis of human breast cancer.Acta Endocrinol (Copenh). 1991;125 Suppl 1:13-26. Acta Endocrinol (Copenh). 1991. PMID: 1801500 Review.
-
The pill and the breast.IPPF Med Bull. 1984 Dec;18(6):1-2. IPPF Med Bull. 1984. PMID: 12313402
-
Breast cancer: potentially predisposing and protecting factors. Role of pregnancy, lactation, and endocrine status.Am J Obstet Gynecol. 1978 Feb 1;130(3):335-58. Am J Obstet Gynecol. 1978. PMID: 341711 Review.
-
Endogenous and exogenous endocrine factors.Hematol Oncol Clin North Am. 1989 Dec;3(4):577-98. Hematol Oncol Clin North Am. 1989. PMID: 2691490 Review.
-
Hormonal and environmental factors affecting cell proliferation and neoplasia in the mammary gland.Prog Clin Biol Res. 1996;394:211-53. Prog Clin Biol Res. 1996. PMID: 8778798 Review.
Cited by
-
Morphologic transformation of human breast epithelial cells MCF-10A: dependence on an oxidative microenvironment and estrogen/epidermal growth factor receptors.Cancer Cell Int. 2010 Sep 1;10:30. doi: 10.1186/1475-2867-10-30. Cancer Cell Int. 2010. PMID: 20809984 Free PMC article.
-
Integrity of the LXXLL motif in Stat6 is required for the inhibition of breast cancer cell growth and enhancement of differentiation in the context of progesterone.BMC Cancer. 2014 Jan 8;14:10. doi: 10.1186/1471-2407-14-10. BMC Cancer. 2014. PMID: 24401087 Free PMC article.
-
MicroRNAs expression in triple negative vs non triple negative breast cancer in Tunisia: interaction with clinical outcome.PLoS One. 2014 Nov 4;9(11):e111877. doi: 10.1371/journal.pone.0111877. eCollection 2014. PLoS One. 2014. PMID: 25369070 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Miscellaneous